
Validea's report on UNITEDHEALTH GROUP INC (UNH), a large-cap growth stock in the Insurance (Accident & Health) sector, assigns a 77% rating based on the Martin Zweig Growth Investor model. This score, while below the 80% 'some interest' threshold, reflects UNH's strong performance in areas like P/E ratio, sales growth, and current quarter earnings, alongside long-term EPS growth. However, the stock notably failed Zweig's criteria for revenue growth relative to EPS and consistent recent earnings growth, indicating areas for improvement within this growth-focused framework.
UnitedHealth Group Inc. (UNH) presents a mixed profile under the Martin Zweig growth investing model, achieving a score of 77%, which is just below the 80% threshold for initial interest. The analysis indicates significant strengths in key fundamental areas, as UNH passes criteria for its P/E ratio, sales growth rate, earnings persistence, and long-term EPS growth. Furthermore, the company shows positive momentum in its most recent reporting period, passing tests for current quarter earnings, year-over-year quarterly earnings, and an acceleration of EPS growth compared to the prior three quarters. Favorable insider transaction data provides an additional layer of confidence. However, the model flags critical weaknesses that temper the bullish outlook. UNH fails the test for revenue growth in relation to EPS growth, suggesting that bottom-line performance may be outpacing top-line expansion, potentially due to margin enhancement or share buybacks rather than core business growth. The company also fails on metrics for consistent earnings growth over the past several quarters and for current EPS growth relative to its own historical rate, indicating that the recent acceleration is not part of a longer, sustained trend and does not match prior peaks.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment